SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBr.smaller Cos. Regulatory News (BSV)

Share Price Information for Br.smaller Cos. (BSV)

Share Price is delayed by 15 minutes
Get Live Data
73.50    0.50 (0.68%)
Bid:
72.00
Ask:
75.00
Spread: 3.00 (4.167%)
Market Cap: £306.68m
BSV Live PriceLast checked at - London Stock Exchange

Intraday Br.smaller Cos. Share Chart

Interim Management Statement

12 Mar 2021 10:55

RNS Number : 1138S
British Smaller Companies VCT PLC
12 March 2021
 

 

British Smaller Companies VCT plc

Interim Management Statement

For the quarter ended 31 December 2020

British Smaller Companies VCT plc (the "Company") presents its interim management statement for the quarter ended 31 December 2020. The statement also includes relevant financial information between the end of the quarter and the date of this statement. A copy of this interim management statement can be found at www.bscfunds.com.

Overview

As announced on 28 January 2021, Total Return increased by 5.3 pence per ordinary share in the quarter to 231.0 pence per ordinary share, representing an increase of 7.8 per cent over the opening Net Asset Value per ordinary share ("NAV"), adjusted for the interim dividend of 2.0 pence per ordinary share paid on 5 October 2020.

During the quarter to 31 December 2020 the Company made two new investments of £4.7 million into Force24 Ltd and Arraco Global Markets Limited and two follow-on investments of £0.7 million into Elucidat Ltd and Ncam Technologies Limited.

Subsequent to the quarter end the Company made two new investments totalling £3.0 million into Vypr Validation Technologies Limited and Outpost VFX Limited.

 

31 December 2020

Movement

30 September 2020

Net Assets (£m)

101.6

4.6

97.0

NAV per share (PPS)

73.6p

3.3p

70.3p

Cumulative dividends paid (PPS)

157.4p

2.0p

155.4p

Total Return (PPS)

231.0p

5.3p

225.7p

Shares in issue

138,108,258

174,014

137,934,244

Performance

The Total Return at 31 December 2020, calculated by reference to the NAV per ordinary share and the cumulative dividends paid per ordinary share, was 231.0 pence per ordinary share compared to 225.7 pence per ordinary share at 30 September 2020. Following the payment of the interim dividend of 2.0 pence per ordinary share on 5 October 2020 cumulative dividends paid increased by 2.0 pence to 157.4 pence per ordinary share (30 September 2020: 155.4 pence per ordinary share).

In the nine months to 31 December 2020 Total Return has increased by 13.1 pence per ordinary share, which is an increase of 20.3 per cent over the NAV per ordinary share of 64.5 pence at 31 March 2020.

 The movement in Total Return in pence per ordinary share is set out in the table below:

 

 

Pence per

ordinary share

Cumulative dividends to 30 September 2020

 

 

155.4

 

Net Asset Value at 30 September 2020

 

 

70.3

 

Total Return at 30 September 2020

 

 

 

225.7

Net underlying increase in portfolio

 

 

5.5

 

Net income after expenses

 

 

(0.2)

 

Change in Total Return

 

 

 

5.3

Total Return at 31 December 2020

 

 

 

231.0

      

 

The unaudited NAV per ordinary share as at 31 December 2020 increased by 3.3 pence per ordinary share to 73.6 pence per ordinary share (30 September 2020: 70.3 pence per ordinary share).

The movement in NAV is set out in the table below:

 

 

£m

Pence per

ordinary share

NAV at 30 September 2020

 

97.0

 

70.3

Net underlying increase in portfolio

7.6

 

5.5

 

Net income after expenses

(0.2)

 

(0.2)

 

Increase in NAV prior to payment of dividends

 

7.4

 

5.3

NAV before dividends

 

104.4

 

75.6

Dividends paid

 

(2.8)

 

(2.0)

NAV at 31 December 2020

 

101.6

 

73.6

Shares in issue

Following the payment of the interim dividend of 2.0 pence per ordinary share on 5 October 2020 the Company issued 1,265,695 ordinary shares under the Company's dividend re-investment scheme.

On 14 December 2020 the Company purchased 1,091,681 ordinary shares of 10 pence each at a price of 65.39 pence per ordinary share. These shares were placed in treasury.

The number of ordinary shares in issue at 31 December 2020 was 138,108,258 (30 September 2020: 137,934,244). In addition, at 31 December 2020 the Company held 13,911,498 ordinary shares in treasury (30 September 2020: 12,819,817).

 

 

Net assets

Net assets at 31 December 2020 comprised the following:

 

£000

% of net assets

Unquoted investments at fair value

67,377

66.3

Listed investment funds

4,997

4.9

Cash and cash equivalents

28,035

27.6

Other net current assets

1,183

1.2

Net assets

101,592

100.0

 

The investment portfolio at 31 December 2020 was comprised as follows:

 

Valuation

£000

Valuation as a % of net assets

 

 

 

Matillion Limited

14,144

13.9

Intelligent Office UK

4,733

4.7

ACC Aviation Group Limited

4,483

4.4

Springboard Research Holdings Limited

4,017

3.9

Deep-Secure Ltd

3,929

3.8

Unbiased EC1 Limited

3,768

3.7

Arcus Global Limited

3,212

3.2

Elucidat Ltd

3,048

3.0

KeTech Enterprises Limited

2,601

2.6

Force24 Ltd

2,400

2.4

 

46,335

45.6

Other investments

21,042

20.7

Total investments

67,377

66.3

Portfolio Performance

The quarter saw a continuing recovery in valuations, reflecting the underlying trading performances of the investment portfolio and a recovery in equity market benchmark multiples.

Investments made since the VCT rule changes in November 2015 now make up 62 per cent of the portfolio by value.

Dividends paid

On 5 October 2020 the Company paid an interim dividend for the year ending 31 March 2021 of 2.0 pence per ordinary share to shareholders on the register as at 21 August 2020, taking cumulative dividends to 157.4 pence per ordinary share.

Fundraising

On 22 February 2021 the Company announced that its offer for subscription to raise up to £7.05 million, pursuant to an offer document issued on 2 February 2021 was fully subscribed and was closed to further applications. On 8 March 2021 the Company announced that its offer had raised net proceeds of £6.84 million and that it had allotted 9,291,092 shares at prices between 75.487 and 75.590 pence per ordinary share.

Outlook

Throughout 2020 many portfolio companies have delivered trading growth despite the challenges of Covid-19. The recent announcements of a roadmap out of lockdown and a sustained vaccination programme are very welcome and it is to be hoped that these positive developments continue. There do remain some frictions around trading with the EU and it is to be hoped that these are short-term in nature and that working practices and protocols emerge that reduce some of these trading frictions. Nonetheless investment demand from UK small businesses seeking to grow has remained strong and it is pleasing that a number of the existing portfolio continue to operate in innovative ways and in many cases are looking to accelerate their expansion plans.

The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulations (EU No. 596/2014). Upon the publication of this announcement via Regulatory Information Service this inside information is now considered to be in the public domain.

12 March 2021

 

For further information please contact:

David Hall YFM Private Equity Limited Tel: 0113 244 1000

Alex Collins Panmure Gordon (UK) Limited Tel: 0207 886 2767

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
QRTGPUPAWUPGGUP
Date   Source Headline
11th Jun 202612:15 pmRNSAnnual Financial Report
20th Apr 202610:00 amRNSAdmission to Trading
1st Apr 20269:00 amRNSIssue of Equity
27th Mar 20264:10 pmRNSTransaction in Own Shares
23rd Mar 202610:45 amRNSPublication of a Supplementary Prospectus
19th Mar 20267:00 amRNS3rd Quarter Results
30th Jan 20267:00 amRNSAdmission of Further Securities to Trading
7th Jan 20269:30 amRNSIssue of Equity
23rd Dec 20258:54 amRNSAmendments to AIFM Agreements
23rd Dec 20258:54 amRNSAmendments to AIFM Agreements
22nd Dec 20259:13 amRNSTransaction in Own Shares
22nd Dec 20259:13 amRNSTransaction in Own Shares
19th Dec 202510:02 amRNSPayment of Dividend and Issue of Equity
19th Dec 202510:02 amRNSPayment of Dividend and Issue of Equity
18th Dec 202512:14 pmRNSClose of Offers to new Applications
18th Dec 202512:14 pmRNSClose of Offers to new Applications
28th Nov 202510:00 amRNSHalf-year Financial Report
20th Nov 20259:00 amRNSOffer Update
11th Nov 20257:00 amRNSDividend Declaration
27th Oct 202511:00 amRNSNominal Capital Reduction
10th Oct 20253:41 pmRNSOffer Update
2nd Oct 20259:00 amRNSOffer Update
25th Sep 20259:04 amRNSPublication of a Prospectus
23rd Sep 20257:00 amRNSTransaction in Own Shares
12th Sep 20257:00 amRNSInterim Management Statement
9th Sep 202512:56 pmRNSResult of AGM
22nd Aug 202510:45 amRNSNew combined offer for subscription
25th Jul 202510:16 amRNSPayment of dividend and issue of Equity
24th Jun 20257:00 amRNSTransaction in Own Shares
13th Jun 20251:30 pmRNSAnnual Financial Report
1st Apr 20258:02 amRNSDirector/PDMR Shareholding
1st Apr 20258:00 amRNSIssue of Equity
26th Mar 20255:13 pmRNSTransaction in Own Shares
24th Mar 202512:45 pmRNSPublication of Supplementary Prospectus
24th Mar 202512:45 pmRNSPublication of Supplementary Prospectus
18th Mar 20251:00 pmRNS3rd Quarter Results
30th Jan 20259:05 amRNSDirector/PDMR Shareholding
30th Jan 20259:00 amRNSIssue of Equity
27th Jan 20259:23 amRNSPayment of dividend and issue of shares
8th Jan 20252:14 pmRNSClose of Offer to new Applications
8th Jan 20252:13 pmRNSClose of Offer to new Applications
20th Dec 20249:26 amRNSPayment of dividend and issue of equity
17th Dec 20247:00 amRNSDividend Declaration
16th Dec 20245:09 pmRNSTransaction in Own Shares
29th Nov 20249:00 amRNSHalf-year Report
20th Nov 20241:00 pmRNSOffer Update
20th Nov 20241:00 pmRNSOffer Update
14th Nov 20247:48 amRNSDividend Declaration
1st Nov 20247:00 amRNSOffer Update
1st Nov 20247:00 amRNSOffer Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.